355 related articles for article (PubMed ID: 2377209)
1. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
2. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
Scholl PR; Diez A; Geha RS
J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
[TBL] [Abstract][Full Text] [Related]
4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
5. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
6. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
7. A toxic shock syndrome toxin-1 peptide that shows homology to mycobacterial heat shock protein 18 is presented as conventional antigen to T cells by multiple HLA-DR alleles.
Ramesh N; Spertini F; Scholl P; Geha R
J Immunol; 1992 Feb; 148(4):1025-30. PubMed ID: 1737925
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal toxins bind to different sites on HLA-DR.
Chintagumpala MM; Mollick JA; Rich RR
J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
[TBL] [Abstract][Full Text] [Related]
9. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.
Choi YW; Herman A; DiGiusto D; Wade T; Marrack P; Kappler J
Nature; 1990 Aug; 346(6283):471-3. PubMed ID: 2377208
[TBL] [Abstract][Full Text] [Related]
10. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
12. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
[TBL] [Abstract][Full Text] [Related]
13. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
14. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
15. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
Moseley AB; Huston DP
J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
[TBL] [Abstract][Full Text] [Related]
18. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
[TBL] [Abstract][Full Text] [Related]
20. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]